Search Results 401-410 of 17548 for metformin

  1. Trilaciclib (intravenous route) - Side effects & uses - Mayo Clinic

    Metformin. Other Interactions. Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions ...

  2. Diabetes - Doctors and departments - Mayo Clinic

    Learn more about the different types of this blood sugar disorder, who's at risk and how each type can be treated.

  3. TUESDAY Q & A: Vitamin B-12 deficiency more common with increasing age - Mayo Clinic News Network

    The diabetes drug metformin also is associated with lower vitamin B-12 levels. Symptoms of B-12 deficiency can be subtle at first. Early symptoms may ...

  4. Diabetes - Doctors and departments - Mayo Clinic

    Learn more about the different types of this blood sugar disorder, who's at risk and how each type can be treated.

  5. Diabetes - Doctors and departments - Mayo Clinic

    Learn more about the different types of this blood sugar disorder, who's at risk and how each type can be treated.

  6. Diabetes - Doctors and departments - Mayo Clinic

    Learn more about the different types of this blood sugar disorder, who's at risk and how each type can be treated.

  7. Phenelzine (oral route) - Side effects & dosage - Mayo Clinic

    Metformin; Nateglinide; Repaglinide; Tolazamide; Tolbutamide. Other Interactions. Certain medicines should not be used at or around the time of eating food or ...

  8. Linezolid (intravenous route) - Side effects & uses - Mayo Clinic

    Metformin; Nateglinide; Repaglinide; Rifampin; Tolazamide; Tolbutamide. Other Interactions. Certain medicines should not be used at or around the time of eating ...

  9. Publications - Ayse Tuba Kendi, M.D. - Mayo Clinic

    Metformin Prevents Tumor Cell Growth and Invasion of Human Hormone Receptor-Positive Breast Cancer (HR+ BC) Cells via FOXA1 Inhibition. Int J Mol Sci. 2024 ...

  10. Patient Preferences for Second-line Type 2 Diabetes Medication Treatment Outcomes - Mayo Clinic

    About this study. It is unknown how patient preferences and values impact the comparative effectiveness of second-line medications for Type 2 diabetes (T2D) ...